EVER PHARMA UK LIMITED
ActiveKey figures
Like most small UK companies, EVER PHARMA UK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Sector comparison
SIC 46460Where the company stands among the 2,974 active companies whose first SIC code is 46460 (Wholesale of pharmaceutical goods).
- CSL BEHRING HOLDINGS LIMITED£11bn
- VIIV HEALTHCARE UK LIMITED£5.7bn
- MCKESSON GLOBAL SOURCING LIMITED£1bn
- MCKESSON MEDICAL-SURGICAL SOURCING LIMITED£999.5m
- PFIZER LIMITED£984m
- ABBOTT LABORATORIES LIMITED£871.8m
- GLAXOSMITHKLINE UK LIMITED£779m
- UNIKERIS LIMITED£642m
- HALEON UK TRADING LIMITED£554.8m
- MUNDIPHARMA MEDICAL COMPANY LIMITED£461.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 2,974. The line on each bar marks the median.
Summary: EVER PHARMA UK LIMITED
What kind of company is it?
EVER PHARMA UK LIMITED is a private limited company registered with Companies House under company number 11388255. It was incorporated on 30 May 2018. Its status is active. The registered office is in Bloxham (OX15). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Net assets were £682,336, up 14.8% on the previous year. Cash at bank and in hand was £573,364. Total assets were £1,581,443 and total liabilities £904,467. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).
How does it compare with similar companies?
Compared with 2,974 active companies whose first SIC code is 46460: By net assets it ranks higher than 74% of them (median £32,520). By total assets it ranks higher than 71% of them (median £255,000). By cash it ranks higher than 75% of them (median £90,159). By number of employees it ranks lower than 65% of them (median 1). It is older than 60% of them (median age 6.2 years).
Does it supply the public sector?
The company is named as a supplier in 2 public contract award notices from NHS England since 2022. 1 of the awards is shared with other suppliers, typically framework agreements.
What do public registers and reports show?
HMRC lists it as an importer of goods, mainly optical, medical and measuring instruments, pharmaceuticals, plastics.
Who runs and controls the company?
The company has 3 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 12 Jun 2027.
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 362,902 | 742,015 | 172,891 | 411,394 | 573,364 |
| Total assets | 1,429,105 | 2,092,944 | 1,997,584 | 1,411,394 | 1,581,443 |
| Total liabilities | 1,113,734 | 1,728,251 | 1,507,726 | 818,901 | 904,467 |
| Net assets / total equity | 316,067 | 364,693 | 492,272 | 594,277 | 682,336 |
| Average number of employees | 10 | 9 | 7 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Public contracts
2 contractsEVER PHARMA UK LIMITED is named as a supplier in 2 public contract award notices from NHS England since 2022. 1 award is shared with other suppliers.
- NHS Framework Agreement for Branded medicines - National‡NHS England · shared by 86 suppliers, up to £526,000,000 in total
- NHS Framework Agreement for Branded Medicines - National Tender‡NHS England · £1
From contract award notices on Contracts Finder (since 2016) and Find a Tender (since 2021), published by the Cabinet Office under the Open Government Licence v3.0. Values are as published by the buyer and usually cover the whole contract term; the total leaves out awards shared between several suppliers, where the published figure is a ceiling for all of them, placeholder values and single figures of £1 billion or more. Notices marked ‡ do not state a company number and were linked by an exact match on the registered name. Contracts below the publication thresholds and those of devolved buyers that publish elsewhere are not included.
Registers and licences
Listed by HMRC as an importer of goods in 8 of the last 12 months on record, most recently July 2026. Main goods: optical, medical and measuring instruments, pharmaceuticals, plastics and leather goods and bags.
From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.
Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.
History
13 events- Financial year 2025 endedAccounts: net assets £682.3k, 0 employees
- Financial year 2024 endedAccounts: net assets £594.3k, 0 employees
- Financial year 2023 endedAccounts: net assets £492.3k, 7 employees
- Financial year 2022 endedAccounts: net assets £364.7k, 9 employees
- Derek Cameron GALLACHER appointedDirector
- Financial year 2021 endedAccounts: net assets £316.1k, 10 employees
- Robert Fletcher CUTTING resignedDirector
- Financial year 2020 endedAccounts: net assets £215.6k, 9 employees
Earlier events (5)
- Dominic Michael BENNING appointedDirector
- Georges KAHWATI appointedDirector
- Robert Fletcher CUTTING appointedDirector
- Friedrich Hillebrand registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.